Jeffrey S. Payne,
CPA
Member, Executive Committee
Chief Financial Officer
Katabat
Mr. Payne is the Chief Financial Officer of Katabat. Katabat is a leading customer experience management solutions company serving the consumer credit industry. Katabat’s platform is a diverse set of products built upon its proprietary strategy, workflow, and customer self-service engines. Prior to Katabat, Mr. Payne held various C level positions in the Life Science and Healthcare industries. He was formerly the Treasurer and SVP of Finance at Biocoat, Inc., a leading manufacturer of lubricious coatings for medical devices. He was also the CFO at Picwell Inc., a healthcare IT company that insurance carriers and brokers use to help consumers select the best healthcare plan.
Prior to Picwell, Mr. Payne was the CFO of Clinical Ink, an eClinical company providing electronic case report forms and patient retention and engagement. Mr. Payne was also the CFO of CRF Health, an international provider of eCOA solutions. During his tenure, CRF Health became the leading provider of eCOA solutions and Mr. Payne oversaw its successful sale to a London based private equity firm. Prior to that, Mr. Payne was the CFO of TRANZACT, a direct to consumer insurance marketing company. Mr. Payne was also the CFO and co-founder of The Credo Group which developed alternative Internet distribution channels for life and health insurance companies and was sold to TRANZACT. Mr. Payne was also the CFO of DiMark Marketing and began his career as an auditor with Arthur Andersen. Mr. Payne is a CPA and CGMA and holds a bachelor of science in accounting from Lehigh University.
Our Leadership
-
PharmD •Chair DIA
Senior Advisor R&D
Bayer AG -
MBA •Immediate Past Chair DIA
President and Chief Executive Officer
Cancer Genetics, Inc. (CGI) -
RPh •Chair-Elect DIA
Head, Product Development Medical Affairs Customer Strategy
F. Hoffmann-La Roche Ltd. -
CPA, CGMA •Secretary/Treasurer DIA
Chief Financial Officer
Katabat -
MS • Global Chief Executive
DIA
-
MD, PhD, DSc •Director DIA
Director, Deputy Qualified Person for Pharmacovigilance, Global Patient Safety
Eli Lilly and Company, Ltd. -
MPharm •Director DIA
Executive Director, Global Regulatory Policy
Merck Sharp & Dohme (Europe) Inc. -
MD •Director DIA
Chief Scientific Officer
Syneos Health -
CPA •Director DIA
Partner, Life Science Industry Practice Group, RSM US -
MD •Director DIA
Chief Medical Officer
Flagship Pioneering -
PhD •Director DIA
Senior Vice President
QIAGEN -
MD, PhD •Director DIA
Vice President and Senior Managing Director, Development & Medical Affairs, GlaxoSmithKline Japan -
PhD •Director DIA
Chairman and Chief Executive Officer
dMed Company Limited -
PharmD •Director DIA
President, R&D Design and Delivery Innovation, IQVIA
-
PharmD • Chair, Executive Committee
-
CPA • Member, Executive Committee -
MBA • Member, Executive Committee -
RPh • Member, Executive Committee -
MS • Member, Executive Committee
-
CPA • Chair, Audit Committee -
MD, PhD, DSc • Member, Audit Committee -
MPharm • Member, Audit Committee -
PharmD • Member, Audit Committee -
PharmD • Member, Audit Committee
-
PhD • Chair, Council of Regulators
Leadership Committee
Japan Pharmaceuticals and Medical Devices Agency Liaison to the DIA Board -
PhD • Council of Regulators
Leadership Committee
European Medicines Agency Liaison to the DIA Board -
MD • Council of Regulators
Leadership Committee
US Food and Drug Administration Liaison to the DIA Board -
PhD • Council of Regulators
Swissmedic Liaison to the DIA Board
-
MS • Global Chief Executive -
MS, CPA • Chief Financial Officer -
-
DIA EMEA -
PhD • Senior Vice President & Managing Director
DIA South Korea and ASEAN -
PhD • Senior Vice President & Managing Director
DIA Americas -
PhD • Senior Vice President & Managing Director
DIA Japan -
RPh, MBA • Senior Vice President & Managing Director
DIA Greater China